<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://ceo.wiki/index.php?action=history&amp;feed=atom&amp;title=Stefano_Pessina</id>
	<title>Stefano Pessina - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://ceo.wiki/index.php?action=history&amp;feed=atom&amp;title=Stefano_Pessina"/>
	<link rel="alternate" type="text/html" href="https://ceo.wiki/index.php?title=Stefano_Pessina&amp;action=history"/>
	<updated>2026-08-25T16:42:15Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://ceo.wiki/index.php?title=Stefano_Pessina&amp;diff=7027&amp;oldid=prev</id>
		<title>Maintenance script: Created comprehensive CEO article: Stefano Pessina, builder of Alliance Boots and CEO of Walgreens Boots Alliance</title>
		<link rel="alternate" type="text/html" href="https://ceo.wiki/index.php?title=Stefano_Pessina&amp;diff=7027&amp;oldid=prev"/>
		<updated>2026-08-25T12:03:15Z</updated>

		<summary type="html">&lt;p&gt;Created comprehensive CEO article: Stefano Pessina, builder of Alliance Boots and CEO of Walgreens Boots Alliance&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Infobox person&lt;br /&gt;
| name         = Stefano Pessina&lt;br /&gt;
| image        = Stefano Pessina bluebackground.jpg&lt;br /&gt;
| image_size   = 250px&lt;br /&gt;
| caption      =&lt;br /&gt;
| birth_date   = {{Birth date and age|1941|6|4}}&lt;br /&gt;
| birth_place  = [[Pescara]], Italy&lt;br /&gt;
| nationality  = Italian&lt;br /&gt;
| citizenship  = Italy; Monaco&lt;br /&gt;
| education    = [[Polytechnic University of Milan]] (nuclear engineering)&lt;br /&gt;
| alma_mater   = Polytechnic University of Milan&lt;br /&gt;
| occupation   = Business executive, investor&lt;br /&gt;
| years_active = 1977–present&lt;br /&gt;
| title        = Former executive vice chairman and chief executive officer of [[Walgreens Boots Alliance]]&lt;br /&gt;
| company      = [[Walgreens Boots Alliance]]&lt;br /&gt;
| employer     = Walgreens Boots Alliance&lt;br /&gt;
| organization = Alliance Santé; Alliance UniChem; Alliance Boots&lt;br /&gt;
| known_for    = Consolidating European pharmaceutical wholesaling and creating Walgreens Boots Alliance&lt;br /&gt;
| residence    = [[Monaco]]&lt;br /&gt;
| partner      = Ornella Barra&lt;br /&gt;
| net_worth    = About US$6.7 billion (2024)&lt;br /&gt;
| signature    =&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Stefano Pessina&amp;#039;&amp;#039;&amp;#039; (born 4 June 1941) is an Italian-born businessman, resident in [[Monaco]], who built one of the largest pharmaceutical wholesaling and retail pharmacy groups in the world through a sequence of more than a thousand acquisitions, and who served as chief executive officer of [[Walgreens Boots Alliance]] from 2015 to 2021 and as its executive chairman thereafter.&lt;br /&gt;
&lt;br /&gt;
Trained as a nuclear engineer at the [[Polytechnic University of Milan]], Pessina took over his family&amp;#039;s small pharmaceutical wholesaling business in Naples in 1977 and spent the following four decades consolidating a fragmented industry. He built the Franco-Italian group Alliance Santé, merged it with the British wholesaler UniChem in 1997 to create Alliance UniChem, and served as that company&amp;#039;s chief executive from 2001 to 2004. In 2006 Alliance UniChem merged with [[Boots Group]], the British pharmacy chain founded in 1849, to form Alliance Boots — the first combination of a major European wholesaler with a major retail chain.&lt;br /&gt;
&lt;br /&gt;
In 2007 Pessina took Alliance Boots private in partnership with Kohlberg Kravis Roberts in a transaction valued at about £11 billion, the largest leveraged buyout of a European company at the time. He then engineered its combination with the American chain Walgreens, agreed in stages from 2012 and completed in December 2014, creating Walgreens Boots Alliance. He became chief executive of the merged company and its largest individual shareholder.&lt;br /&gt;
&lt;br /&gt;
Pessina&amp;#039;s approach was unusual among executives of comparable scale in that he operated as a principal rather than as a manager: he was consistently the largest shareholder in the businesses he ran, financed acquisitions against his own holdings, and preferred private ownership to public markets. Walgreens Boots Alliance was taken private by Sycamore Partners in a transaction completed in August 2025, valuing the company at about US$10 billion; Pessina reinvested the proceeds of his roughly 17 percent holding. &amp;#039;&amp;#039;Forbes&amp;#039;&amp;#039; estimated his net worth at about US$6.7 billion in 2024.&lt;br /&gt;
&lt;br /&gt;
== Background: European pharmaceutical distribution ==&lt;br /&gt;
&lt;br /&gt;
The industry in which Pessina made his career was, when he entered it, among the most fragmented in Europe, and its consolidation is the substance of his record.&lt;br /&gt;
&lt;br /&gt;
Pharmaceutical wholesaling occupies the position between manufacturers and pharmacies. It is a business of logistics and working capital rather than of products: margins are thin, volumes are large, delivery frequency is high — European pharmacies commonly expect several deliveries a day — and the operator&amp;#039;s advantage comes from density of coverage and efficiency of distribution rather than from anything proprietary.&lt;br /&gt;
&lt;br /&gt;
The structure was national and often regional. Each European country had its own wholesalers, its own regulations on pharmacy ownership, its own pricing arrangements and its own reimbursement systems. Many countries restricted pharmacy ownership to qualified pharmacists, which prevented the emergence of retail chains and kept the customer base fragmented as well. Cross-border operators barely existed.&lt;br /&gt;
&lt;br /&gt;
The conditions favoured consolidation on any measure of industrial logic, and resisted it in practice because the regulatory obstacles were national and numerous. Pessina&amp;#039;s contribution was to treat the obstacles as soluble one country at a time, and to keep buying.&lt;br /&gt;
&lt;br /&gt;
== Early life and education ==&lt;br /&gt;
&lt;br /&gt;
Pessina was born in [[Pescara]], on the Adriatic coast of Italy, on 4 June 1941. He studied nuclear engineering at the [[Polytechnic University of Milan]], graduating in the 1960s, and worked initially as an engineer and then in management consultancy.&lt;br /&gt;
&lt;br /&gt;
The technical training is frequently cited in accounts of his career as the source of his approach to distribution, which he treated as a systems problem — a network to be optimized for coverage, delivery frequency and working capital — rather than as a commercial one.&lt;br /&gt;
&lt;br /&gt;
== Career ==&lt;br /&gt;
&lt;br /&gt;
=== Alliance Santé ===&lt;br /&gt;
&lt;br /&gt;
In 1977 Pessina took over his family&amp;#039;s pharmaceutical wholesaling business in Naples, a small regional operator. He was 36.&lt;br /&gt;
&lt;br /&gt;
He began acquiring other Italian wholesalers immediately, and then moved across borders, buying in France, Spain, Portugal, the Netherlands, Switzerland and elsewhere. The resulting group, Alliance Santé, became a Franco-Italian wholesaler with operations across several European markets, assembled from a large number of small purchases rather than through any single transformative deal.&lt;br /&gt;
&lt;br /&gt;
His method was consistent throughout. He bought family-owned regional wholesalers, frequently retaining their managers and often paying partly in shares so that the sellers became shareholders in the enlarged group; he integrated the logistics and the purchasing while leaving local customer relationships intact; and he moved on. Over his career he is estimated to have completed more than 1,500 acquisitions.&lt;br /&gt;
&lt;br /&gt;
=== Alliance UniChem ===&lt;br /&gt;
&lt;br /&gt;
In 1997 Alliance Santé merged with UniChem, a British pharmaceutical wholesaler that also owned the Moss Pharmacy chain, to create Alliance UniChem. Pessina joined the board and became the company&amp;#039;s largest shareholder; he served as chief executive from 2001 to 2004 and then as executive deputy chairman.&lt;br /&gt;
&lt;br /&gt;
The merger gave the group a position in the United Kingdom, the largest European market in which pharmacy ownership was not restricted to individual pharmacists, and therefore the one in which retail chains could be built. Alliance UniChem expanded its retail operations substantially over the following years.&lt;br /&gt;
&lt;br /&gt;
=== Alliance Boots ===&lt;br /&gt;
&lt;br /&gt;
In 2006 Alliance UniChem merged with Boots Group, whose Boots the Chemists chain was among the most recognized retail brands in Britain, in a transaction valued at about £7 billion that created Alliance Boots. The combination joined a leading European wholesaler with a leading retail pharmacy chain — a vertical integration that had not previously been achieved at that scale in Europe.&lt;br /&gt;
&lt;br /&gt;
Pessina was executive deputy chairman and the largest shareholder.&lt;br /&gt;
&lt;br /&gt;
=== The 2007 buyout ===&lt;br /&gt;
&lt;br /&gt;
In 2007 Pessina partnered with Kohlberg Kravis Roberts to take Alliance Boots private, in a contested process that involved a competing bid from Terra Firma. The transaction, valued at about £11 billion, was the largest leveraged buyout of a European company at that point and the first of a FTSE 100 constituent.&lt;br /&gt;
&lt;br /&gt;
The timing was fortunate in one sense and dangerous in another: the deal closed shortly before the credit markets seized, and the resulting debt burden had to be carried through the financial crisis and the recession that followed. The business was restructured, costs were reduced and debt was repaid over the following years, and the buyout is generally assessed as among the more successful large leveraged transactions of the period.&lt;br /&gt;
&lt;br /&gt;
Pessina served as executive chairman of Alliance Boots from 2007 to 2014, operating the company as a private business — an arrangement he had long said he preferred, on the ground that pharmaceutical distribution requires investment on horizons longer than quarterly reporting accommodates.&lt;br /&gt;
&lt;br /&gt;
=== Walgreens Boots Alliance ===&lt;br /&gt;
&lt;br /&gt;
The combination with Walgreens was executed in two stages. In August 2012, Walgreens acquired 45 percent of Alliance Boots for about US$6.7 billion in cash and stock, with an option to acquire the remainder after three years. Pessina received a substantial holding in Walgreens and joined its board.&lt;br /&gt;
&lt;br /&gt;
Walgreens exercised the option, and the second stage completed on 31 December 2014, creating Walgreens Boots Alliance. Pessina emerged with roughly 7.7 percent of the combined company and became its largest individual shareholder; his partner Ornella Barra also held a senior executive position in the group.&lt;br /&gt;
&lt;br /&gt;
He was appointed acting chief executive in January 2015 and confirmed as permanent chief executive later that year.&lt;br /&gt;
&lt;br /&gt;
=== As chief executive ===&lt;br /&gt;
&lt;br /&gt;
The company Pessina led was the largest retail pharmacy operator in the United States and Europe, with more than 13,000 stores, and one of the largest pharmaceutical wholesalers in the world.&lt;br /&gt;
&lt;br /&gt;
His principal strategic move as chief executive was an attempt to acquire the rival American chain Rite Aid, agreed in October 2015 for about US$9.4 billion. The transaction was opposed by the Federal Trade Commission on competition grounds, was repeatedly restructured and repriced over two years, and was ultimately abandoned in June 2017; Walgreens instead purchased about 1,900 Rite Aid stores for approximately US$4.4 billion.&lt;br /&gt;
&lt;br /&gt;
The wider period was difficult for the business. Reimbursement rates for prescriptions declined, pharmacy benefit managers exerted increasing pricing pressure, competition from Amazon and from vertically integrated rivals such as CVS Health intensified, and the front-of-store retail business lost ground. The company&amp;#039;s share price fell substantially over the second half of Pessina&amp;#039;s tenure.&lt;br /&gt;
&lt;br /&gt;
Pessina stepped down as chief executive in March 2021, succeeded by Rosalind Brewer, and became executive chairman.&lt;br /&gt;
&lt;br /&gt;
=== Take-private, 2025 ===&lt;br /&gt;
&lt;br /&gt;
Sycamore Partners completed a transaction taking Walgreens Boots Alliance private in August 2025, at US$11.45 per share and a valuation of about US$10 billion — a fraction of the company&amp;#039;s value at the time of the merger a decade earlier. Pessina, who held approximately 17 percent, reinvested his proceeds in the private company.&lt;br /&gt;
&lt;br /&gt;
The outcome returned the business to the private ownership Pessina had consistently favoured, under a structure in which its constituent parts were expected to be separated.&lt;br /&gt;
&lt;br /&gt;
== Approach ==&lt;br /&gt;
&lt;br /&gt;
Pessina&amp;#039;s method was consistent across four decades and is unusual in several respects.&lt;br /&gt;
&lt;br /&gt;
He operated as an owner rather than as a professional manager. In each successive entity — Alliance Santé, Alliance UniChem, Alliance Boots, Walgreens Boots Alliance — he was the largest individual shareholder, and he financed acquisitions partly against his own holdings. His personal wealth was therefore tied to the outcome in a way that is uncommon among executives of companies of comparable size.&lt;br /&gt;
&lt;br /&gt;
He preferred private ownership, arguing that the investment cycles in distribution and pharmacy are longer than public markets tolerate, and he acted on the preference twice: in the 2007 buyout and in the 2025 take-private.&lt;br /&gt;
&lt;br /&gt;
He acquired continuously rather than episodically. The scale of his career total — more than 1,500 transactions — reflects a strategy of buying small regional operators repeatedly rather than pursuing transformative deals, with the large mergers occurring only when the accumulated base made them possible.&lt;br /&gt;
&lt;br /&gt;
He retained sellers as shareholders and managers where he could, which reduced the cash cost of acquisitions and eased integration in an industry where customer relationships were local and personal.&lt;br /&gt;
&lt;br /&gt;
== Personal life ==&lt;br /&gt;
&lt;br /&gt;
Pessina has lived in [[Monaco]] for many years and holds Monegasque residence. His partner is Ornella Barra, an Italian pharmacist who worked with him from the early stages of his career in Italy and who held senior executive positions in Alliance UniChem, Alliance Boots and Walgreens Boots Alliance, latterly as chief operating officer of the group&amp;#039;s international division. The professional partnership, sustained across several decades and multiple companies, has been a consistent feature of accounts of his career.&lt;br /&gt;
&lt;br /&gt;
He has two children from an earlier marriage.&lt;br /&gt;
&lt;br /&gt;
He has generally avoided public visibility, giving few interviews and taking no prominent role in public debate, with one exception: in 2015 he was reported as saying that a Labour government under Ed Miliband would be a catastrophe for Britain, a remark that prompted criticism in the British press given his Monaco residence and the tax arrangements of Alliance Boots, and for which he subsequently expressed regret at having spoken.&lt;br /&gt;
&lt;br /&gt;
== Assessment ==&lt;br /&gt;
&lt;br /&gt;
Pessina&amp;#039;s record divides into two clearly separable parts.&lt;br /&gt;
&lt;br /&gt;
The first, running from 1977 to roughly 2014, is a case of industry consolidation executed with unusual persistence. He entered a fragmented, low-margin, nationally segmented industry and assembled from it a pan-European group, then integrated wholesaling with retail, then combined the result with the largest American chain. The construction of Walgreens Boots Alliance from a family wholesaler in Naples is, by any measure, a substantial industrial achievement, and it made him a billionaire several times over.&lt;br /&gt;
&lt;br /&gt;
The second, from 2015 onward, is less favourable. The merged company faced structural pressures across both its major markets that Pessina&amp;#039;s acquisitive method could not address, since the problem was not fragmentation but declining reimbursement, the growth of pharmacy benefit managers, and competition from vertically integrated and online rivals. The Rite Aid transaction failed on competition grounds after two years, the share price declined substantially, and the company was ultimately sold at a value far below its worth at the merger.&lt;br /&gt;
&lt;br /&gt;
Assessments differ on how much of the second period is attributable to management. The pressures on American retail pharmacy affected every operator, and CVS Health&amp;#039;s response — vertical integration into insurance through the Aetna acquisition — was available to Walgreens only at a scale and cost it could not match. Critics argue that Pessina&amp;#039;s strengths were in acquisition and integration rather than in operating a mature retail business under structural decline, and that the two required different things.&lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
&lt;br /&gt;
* [[Walgreens Boots Alliance]]&lt;br /&gt;
* [[Alliance Boots]]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
{{reflist}}&lt;br /&gt;
&lt;br /&gt;
== External links ==&lt;br /&gt;
&lt;br /&gt;
* [https://www.walgreensbootsalliance.com/ Walgreens Boots Alliance]&lt;br /&gt;
&lt;br /&gt;
{{Authority control}}&lt;br /&gt;
&lt;br /&gt;
{{DEFAULTSORT:Pessina, Stefano}}&lt;br /&gt;
[[Category:Chief executive officers]]&lt;br /&gt;
[[Category:Italian chief executives]]&lt;br /&gt;
[[Category:1941 births]]&lt;br /&gt;
[[Category:Living people]]&lt;br /&gt;
[[Category:Italian business executives]]&lt;br /&gt;
[[Category:Italian billionaires]]&lt;/div&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
</feed>